Top

Published in:

Open Access 01-08-2021 | Antibiotic | Original Article

Management of superficial and deep surgical site infection: an international multidisciplinary consensus

Authors: Gabriele Sganga, Mohamed Baguneid, Pascal Dohmen, Evangelos J. Giamarellos-Bourboulis, Emilio Romanini, Athanassios Vozikis, Christian Eckmann

Published in: Updates in Surgery | Issue 4/2021

Abstract

Surgical site infections represent a considerable burden for healthcare systems. To obtain a consensus on the impact and future clinical and economic needs regarding SSI management in an era of multidrug resistance. A modified Delphi method was used to obtain consensus among experts from five European countries. The Delphi questionnaire was assembled by a steering committee, verified by a panel of experts and administered to 90 experts in 8 different surgical specialities (Abdominal, Cancer, Cardiac, General surgery, Orthopaedic, Thoracic, Transplant and Vascular and three other specialities (infectious disease, internal medicine microbiology). Respondents (n = 52) reached consensus on 62/73 items including that resistant pathogens are an increasing matter of concern and increase both treatment complexity and the length of hospital stay. There was strong positive consensus on the cost-effectiveness of early discharge (ED) programs, improvement of quality of life with ED and association between increased length of stay and economic burden to the hospital. However, established ED protocols were not widely available in their hospitals. Respondents expressed a positive consensus on the usefulness of antibiotics that allow ED. Surgeons are aware of their responsibility in an interdisciplinary team for the treatment of SSI, and of the impact of multidrug-resistant bacteria in the context of SSI. Reducing the length of hospital stays by applying ED protocols and implementing new treatment alternatives is crucial to reduce harm to patients and costs for the hospital.

Available only for authorised users

Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, The Healthcare-Associated Infections Prevalence Study Group et al (2018) Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill 23:1800516. https://doi.org/10.2807/1560-7917.ES.2018.23.46.1800516CrossRefPubMedCentral

Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T et al (2016) Burden of six healthcare-associated infections on european population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med 13:e1002150. https://doi.org/10.1371/journal.pmed.1002150CrossRefPubMedPubMedCentral

Wolford HM, Hatfield KM, Paul P, Yi SH, Slayton RB (2018) The projected burden of complex surgical site infections following hip and knee arthroplasties in adults in the United States, 2020 through 2030. Infect Control Hosp Epidemiol 39:1189–1195. https://doi.org/10.1017/ice.2018.184CrossRefPubMedPubMedCentral

Gaynes RP (2000) Surgical-site infections and the NNIS SSI Risk Index: room for improvement. Infect Control Hosp Epidemiol 21:184–185CrossRefPubMed

Lakomkin N, Sathiyakumar V, Wick B, Shen MS, Jahangir AA, Mir H et al (2017) Incidence and predictive risk factors of postoperative sepsis in orthopedic trauma patients. J Orthop Traumatol 18:151–158. https://doi.org/10.1007/s10195-016-0437-4CrossRefPubMed

Hlava N, Niemann CU, Gropper MA, Melcher ML (2009) Postoperative infectious complications of abdominal solid organ transplantation. J Intensive Care Med 24:3–17. https://doi.org/10.1177/0885066608327127CrossRefPubMed

Martin ET, Kaye KS, Knott C, Nguyen H, Santarossa M, Evans R et al (2016) Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37:88–99. https://doi.org/10.1017/ice.2015.249CrossRefPubMed

Altemeier WA, Culbertson WR, Hummel RP (1968) Surgical considerations of endogenous infections—sources, types, and methods of control. Surg Clin N Am 48:227–240CrossRefPubMed

Sganga G, Tascini C, Sozio E, Carlini M, Chirletti P, Cortese F et al (2016) Focus on the prophylaxis, epidemiology and therapy of methicillin-resistant Staphylococcus aureus surgical site infections and a position paper on associated risk factors: the perspective of an Italian group of surgeons. World J Emerg Surg 11:26. https://doi.org/10.1186/s13017-016-0086-1CrossRefPubMedPubMedCentral

10.

Alexiou K, Drikos I, Terzopoulou M, Sikalias N, Ioannidis A, Economou N (2017) A prospective randomised trial of isolated pathogens of surgical site infections (SSI). Ann Med Surg (Lond) 21:25–29. https://doi.org/10.1016/j.amsu.2017.07.045CrossRef

11.

Nodaras C, Kotsaki A, Tziolos N, Kontopoulou T, Akinosoglou K, Chrisanthakopoulou M et al (2019) Microbiology of acute bacterial skin and skin-structure infections in Greece: a proposed clinical prediction score for the causative pathogen. Int J Antimicrob Agents 54:750–756. https://doi.org/10.1016/j.ijantimicag.2019.08.020CrossRefPubMed

12.

Weigelt JA, Lipsky BA, Tabak YP, Derby KG, Kim M, Gupta V (2010) Surgical site infections: causative pathogens and associated outcomes. Am J Infect Control 38:112–120. https://doi.org/10.1016/j.ajic.2009.06.010CrossRefPubMed

13.

Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP et al (1985) The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 121:182–205CrossRefPubMed

14.

Brandt C, Sohr D, Behnke M, Daschner F, Rüden H, Gastmeier P (2006) Reduction of surgical site infection rates associated with active surveillance. Infect Control Hosp Epidemiol 27:1347–1351. https://doi.org/10.1086/509843CrossRefPubMed

15.

Delgado-Rodríguez M, Gómez-Ortega A, Sillero-Arenas M, Llorca J (2001) Epidemiology of surgical-site infections diagnosed after hospital discharge: a prospective cohort study. Infect Control Hosp Epidemiol 22:24–30CrossRefPubMed

16.

Huotari K, Lyytikäinen O, Hospital Infection Surveillance Team (2006) Impact of postdischarge surveillance on the rate of surgical site infection after orthopedic surgery. Infect Control Hosp Epidemiol 27:1324–1329CrossRefPubMed

17.

Woelber E, Schrick EJ, Gessner BD, Evans HL (2016) Proportion of surgical site infections occurring after hospital discharge: a systematic review. Surg Infect (Larchmt) 17:510–519. https://doi.org/10.1089/sur.2015.241CrossRef

18.

Bluebelle Study Group (2019) Validation of the Bluebelle Wound Healing Questionnaire for assessment of surgical-site infection in closed primary wounds after hospital discharge. Br J Surg 106:226–235. https://doi.org/10.1002/bjs.11008CrossRef

19.

Sartelli M, Pagani L, Iannazzo S, Moro ML, Viale P, Pan A et al (2020) A proposal for a comprehensive approach to infections across the surgical pathway. World J Emerg Surg 15:13. https://doi.org/10.1186/s13017-020-00295-3CrossRefPubMedPubMedCentral

20.

Fink A, Kosecoff J, Chassin M, Brook RH (1984) Consensus methods: characteristics and guidelines for use. Am J Public Health 74:979–983CrossRefPubMedPubMedCentral

21.

Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 13:606–608CrossRefPubMed

22.

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for Prevention of Surgical Site Infection, 1999 Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27:97–132CrossRefPubMed

23.

European Centre for Disease Prevention and Control (2017) Healthcare-associated infections: surgical site infections. In: ECDC. Annual epidemiological report for 2015. Stockholm: ECDC. https://www.ecdc.europa.eu/en/publications-data/healthcare-associated-infections-surgical-site-infections-annual-epidemiological. Accessed 12 June 2020

24.

European Centre for Disease Prevention and Control (2019) Surveillance of antimicrobial resistance in Europe 2018. Stockholm: ECDC. https://www.ecdc.europa.eu/sites/default/files/documents/surveillance-antimicrobial-resistance-Europe-2018.pdf. Accessed 12 June 2020

25.

Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT, European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group et al (2017) Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis 17:153–163. https://doi.org/10.1016/S1473-3099(16)30257-2CrossRefPubMed

26.

Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Burden of AMR Collaborative Group et al (2019) Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 19:56–66. https://doi.org/10.1016/S1473-3099(18)30605-4CrossRefPubMedPubMedCentral

27.

Dawson-Hahn EE, Mickan S, Onakpoya I, Roberts N, Kronman M, Butler CC et al (2017) Short-course versus long-course oral antibiotic treatment for infections treated in outpatient settings: a review of systematic reviews. Fam Pract 34:511–519. https://doi.org/10.1093/fampra/cmx037CrossRefPubMedPubMedCentral

28.

Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD (2010) Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340:c2096. https://doi.org/10.1136/bmj.c2096CrossRefPubMed

29.

Annoni F, Grimaldi D, Taccone FS (2020) Individualized antibiotic therapy in the treatment of severe infections. Expert Rev Anti Infect Ther 18:27–35. https://doi.org/10.1080/14787210.2020.1696192CrossRefPubMed

30.

US Food and Drug Administration, Center for Drug Evaluation and Research (2013) Guidance for Industry. Acute Bacterial Skin and Skin Structure Infections: Developing Drugs for Treatment. Draft Guidance. https://www.fda.gov/media/71052/download. Accessed 12 June 2020

31.

Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C (2017) Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect 96:1–15. https://doi.org/10.1016/j.jhin.2017.03.004CrossRefPubMed

32.

de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB (2009) Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 37:387–397. https://doi.org/10.1016/j.ajic.2008.12.010CrossRefPubMed

33.

Anderson DJ, Kaye KS, Chen LF, Schmader KE, Choi Y, Sloane R et al (2009) Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS ONE 4:e8305. https://doi.org/10.1371/journal.pone.0008305CrossRefPubMedPubMedCentral

34.

Eckmann C, Lawson W, Nathwani D, Solem CT, Stephens JM, Macahilig C et al (2014) Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria. Int J Antimicrob Agents 44:56–64. https://doi.org/10.1016/j.ijantimicag.2014.04.007CrossRefPubMed

35.

Restelli U, Bonfanti M, Croce D, Grau S, Metallidis S, Moreno Guillén S et al (2019) Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysis. BMJ Open 9:e031356. https://doi.org/10.1136/bmjopen-2019-031356CrossRefPubMedPubMedCentral

36.

Nathwani D, Eckmann C, Lawson W, Solem CT, Corman S, Stephens JM et al (2014) Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe. BMC Infect Dis 14:476. https://doi.org/10.1186/1471-2334-14-476CrossRefPubMedPubMedCentral

37.

Eells SJ, Nguyen M, Jung J, Macias-Gil R, May L, Miller LG (2016) Relationship between adherence to oral antibiotics and postdischarge clinical outcomes among patients hospitalized with Staphylococcus aureus skin infections. Antimicrob Agents Chemother 60:2941–2948. https://doi.org/10.1128/AAC.02626-15CrossRefPubMedPubMedCentral

38.

Stargardt T, Eckmann C, Bouza E, Rossolini GM, Grossi PA (2018) Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey. Eur J Clin Microbiol Infect Dis 37:1611–1618. https://doi.org/10.1007/s10096-018-3264-0CrossRefPubMedPubMedCentral

39.

Roberts KD, Sulaiman RM, Rybak MJ (2015) Dalbavancin and oritavancin: an innovative approach to the treatment of gram-positive infections. Pharmacotherapy 35:935–948. https://doi.org/10.1002/phar.1641CrossRefPubMed

40.

Sganga G, Tascini C, Sozio E, Colizza S (2017) Early recognition of methicillin-resistant Staphylococcus aureus surgical site infections using risk and protective factors identified by a group of Italian surgeons through Delphi method. World J Emerg Surg 12:25. https://doi.org/10.1186/s13017-017-0136-3CrossRefPubMedPubMedCentral

Title: Management of superficial and deep surgical site infection: an international multidisciplinary consensus
Authors: Gabriele Sganga
Mohamed Baguneid
Pascal Dohmen
Evangelos J. Giamarellos-Bourboulis
Emilio Romanini
Athanassios Vozikis
Christian Eckmann
Publication date: 01-08-2021
Publisher: Springer International Publishing
Keyword: Antibiotic
Published in: Updates in Surgery / Issue 4/2021
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI: https://doi.org/10.1007/s13304-021-01029-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Management of superficial and deep surgical site infection: an international multidisciplinary consensus

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2021

Cytoreductive surgery and mitomycin C hyperthermic intraperitoneal chemotherapy with CO2 recirculation (HIPEC-CO2) for colorectal cancer peritoneal metastases: analysis of short-term outcomes

Total pancreatectomy: how, when and why?

Preoperative assessment of skeletal muscle mass during magnetic resonance enterography in patients with Crohn’s disease

The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study

Comparison of the radiofrequency ablation versus laparoscopic adrenalectomy for aldosterone-producing adenoma: a meta-analysis of perioperative outcomes and safety

Micronvasive behaviour of single small hepatocellular carcinoma: which treatment?